Periadventitial adipose-derived stem cell treatment halts elastase-induced abdominal aortic aneurysm progression

Kory J. Blose, Terri L. Ennis, Batool Arif, Justin S. Weinbaum, John A. Curci, David A. Vorp

Research output: Contribution to journalArticlepeer-review

11 Scopus citations

Abstract

Aim: Demonstrate that periadventitial delivery of adipose-derived mesenchymal stem cells (ADMSCs) slows aneurysm progression in an established murine elastase-perfusion model of abdominal aortic aneurysm (AAA).

Materials & methods: AAAs were induced in C57BL/6 mice using porcine elastase. During elastase perfusion, a delivery device consisting of a subcutaneous port, tubing and porous scaffold was implanted. Five days after elastase perfusion, 100,000 ADMSCs were delivered through the port to the aorta. After sacrifice at day 14, analyzed metrics included aortic diameter and structure of aortic elastin.

Results: ADMSC treated aneurysms had a smaller diameter and less fragmented elastin versus saline controls.

Conclusion: Periadventitial stem cell delivery prevented the expansion of an established aneurysm between days 5 and 14 after elastase perfusion.

Original languageEnglish (US)
Pages (from-to)733-741
Number of pages9
JournalRegenerative Medicine
Volume9
Issue number6
DOIs
StatePublished - Nov 1 2014

All Science Journal Classification (ASJC) codes

  • Biomedical Engineering
  • Embryology

Fingerprint Dive into the research topics of 'Periadventitial adipose-derived stem cell treatment halts elastase-induced abdominal aortic aneurysm progression'. Together they form a unique fingerprint.

Cite this